Cardiol Therapeutics is a clinical-stage biotechnology company based in Canada that develops pharmaceutical formulations of cannabidiol for cardiovascular disease. Its work centres on a purified cannabidiol product candidate being studied for conditions such as heart failure and myocarditis, along with earlier-stage research into other cannabinoid-derived medicines. The company's customers and collaborators are the clinical investigators, hospitals and research institutions that take part in its studies, rather than consumers buying cannabis products.
The shares are listed on the Toronto Exchange in Canada under the code CRDL, and the price on this page is in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #604 of 868 on the Toronto Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Canada yet.
TrendWeak
46/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-12.9%
From 52-week high-50.3%
MomentumWeak
47/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-7.1%
6-month return-23.8%
12-month, skipping last month80.8%
Stability (higher is calmer)Weak
22/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)63.2%
Worst drawdown, 1 year (smaller is calmer)-50.3%
LiquidityWeak
48/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.62M CAD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Canada when fundamentals data for this market is added. All Canada stocks.
52-wk range 1.225 – 3.230Daily closes, split-adjusted
Signals
50-day average2.426
200-day average1.803
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.130
Technical summary
Daily
Bearish
4 bullish · 0 neutral · 12 bearish
Weekly
Strongly bearish
1 bullish · 1 neutral · 10 bearish
Monthly
Bearish
2 bullish · 1 neutral · 5 bearish
Moving averages (daily)
SMA 10
1.73
Bearish
EMA 10
1.76
Bearish
SMA 20
2.07
Bearish
EMA 20
1.99
Bearish
SMA 50
2.43
Bearish
EMA 50
2.17
Bearish
SMA 100
2.02
Bearish
EMA 100
2.09
Bearish
SMA 200
1.80
Bearish
EMA 200
1.93
Bearish
Oscillators (daily)
RSI (14)
18.31
Bullish
MACD (12, 26)
-0.26
Bearish
Momentum (12)
-33.76
Bearish
Stochastic %K (14)
4.49
Bullish
Williams %R (14)
-95.51
Bullish
CCI (20)
-103.7
Bullish
Pivot points (classic, last session)
S3
1.49
S2
1.51
S1
1.54
Pivot
1.56
R1
1.59
R2
1.61
R3
1.64
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in CAD. Educational only, not financial advice.
